Related by context. All words. (Click for frequent words.) 76 forodesine 74 Traficet EN 74 Xanafide 74 MAGE A3 ASCI 74 oral prodrug 74 selective modulator 73 atacicept 73 thetreatment 73 PSN# [002] 73 beta 1a 73 CTAP# Capsules 73 Virulizin ® 73 Panzem R 73 lumiliximab 73 Onconase 73 orally administered inhibitor 73 HuMax EGFr 73 Phase IIIb clinical 73 liposomal formulation 73 IMA# 72 RhuDex ® 72 pharmacodynamic PD 72 CIMZIA ™ 72 riociguat 72 HuLuc# 72 PDE4 inhibitor 72 p# inhibitor 72 mertansine 72 PRT# 72 Symadex 72 Nexavar sorafenib 72 INCB# [001] 72 elotuzumab 72 octreotide implant 72 generation purine nucleoside 72 DDP# 72 Archexin 72 velafermin 72 Capesaris 72 viral kinetics 72 volociximab 72 cMET 72 phase IIa clinical 72 Phase Ib study 72 PXD# 72 YONDELIS 72 Tasimelteon 71 Cimzia TM 71 antibody MAb 71 CIMZIA TM certolizumab pegol 71 preclinical efficacy 71 fosbretabulin 71 PEG SN# 71 humanized monoclonal 71 EndoTAG TM -1 71 CBLC# 71 PI3K/Akt pathway inhibitor 71 LHRH antagonists 71 alvespimycin 71 CINTREDEKIN BESUDOTOX 71 interferon gamma 1b 71 novel VDA molecule 71 LymphoStat B belimumab 71 Aptivus ® 71 Bicifadine 71 Alvesco R 71 Panzem R NCD 71 Azedra 71 lomitapide 71 eniluracil 71 HuMax CD# 71 Degarelix 71 PSMA ADC 71 mGluR2 NAM 71 evaluating tivozanib 71 sunitinib malate 71 MGd 71 reslizumab 71 pertuzumab 71 enzastaurin 71 Intravenous CP 71 immune modulating 71 Phase #b/#a clinical 71 Factor VIIa 71 ganetespib 71 EOquin TM 71 trodusquemine 71 corticosteroid dexamethasone 71 Evoltra ® 71 Tarceva TM 71 Aflibercept 71 PANVAC VF 71 AZILECT ® 71 ZACTIMA 71 ELACYT 71 Phase 1a clinical 71 Quinamed 71 Natalizumab 71 protein tyrosine phosphatase 1B 71 SNT-MC#/idebenone 70 CCR9 antagonist 70 alkylating agent 70 SNT MC# 70 receptor tyrosine kinase inhibitor 70 AKT inhibitor 70 CIMZIA TM 70 HQK 70 PEGylated Fab fragment 70 erythropoietic 70 canakinumab 70 omega interferon 70 Aplidin 70 Safinamide 70 elacytarabine 70 intranasal formulation 70 decitabine 70 Cleviprex TM clevidipine 70 angiogenesis inhibitor 70 Vidaza azacitidine 70 Personalized Immunotherapy 70 vascular disrupting agents 70 OMNARIS HFA 70 ARIKACE ™ 70 JAK inhibitors 70 TroVax ® 70 sorafenib tablets 70 nucleoside analog 70 JAK2 inhibitor 70 XmAb# 70 SPRYCEL ® 70 Inhalation Solution 70 CG# [003] 70 JAK inhibitor 70 immunomodulatory therapy 70 phase IIb clinical 70 DU #b 70 tanespimycin 70 pan HDAC inhibitor 70 PD LID 70 regorafenib 70 relapsed MM 70 nucleotide analog 70 GW# [003] 70 preclinically 70 receptor inhibitor 70 APTIVUS 70 lucinactant 70 ACOMPLIA R 70 miconazole Lauriad ® 70 oral salmon calcitonin 70 Pemetrexed 70 CYT# potent vascular disrupting 70 OMP #M# 70 ENMD # 70 Catena ® 70 cilengitide 70 OXi# 70 CCX# 70 FOLOTYN ® 70 diabetic neuropathic pain 70 teduglutide 70 lenalidomide dexamethasone 70 TKM ApoB 70 investigational humanized monoclonal antibody 70 JAK1 70 metastatic malignant 70 erlotinib Tarceva ® 70 TH# [003] 70 proteasome inhibitor 70 BrachySil TM 70 selective inhibition 70 Clolar ® 70 deforolimus 70 docetaxel Taxotere ® 70 OvaRex R 70 CRMD# 70 subcutaneously administered 70 Plicera 69 Elagolix 69 Abiraterone acetate 69 teriflunomide 69 PNP inhibitor 69 antithrombotic 69 HGS ETR2 69 thalidomide Thalomid 69 targeting CD# 69 Bezielle 69 TRO# 69 ZOLINZA 69 vascular disrupting agent 69 Phase IIb trials 69 salmeterol fluticasone 69 brivaracetam 69 prucalopride 69 Apoptone 69 VA# [002] 69 TLK# 69 insulin sensitizing 69 AZILECT R 69 Cloretazine 69 Imprime PGG 69 huN# DM1 69 R sorafenib tablets 69 Altastaph 69 CDK inhibitor 69 Pazopanib 69 subcutaneous formulation 69 catheter occlusion 69 OHR/AVR# 69 dasatinib Sprycel 69 Vidofludimus 69 BCR ABL inhibitor 69 AAG geldanamycin analog 69 acetonide FA 69 cobiprostone 69 Androxal TM 69 sJIA 69 Dapagliflozin 69 oral ridaforolimus 69 TNF alpha inhibitor 69 induced macular edema 69 relapsing multiple sclerosis 69 Telatinib 69 #ME# 69 acyclovir Lauriad R 69 GAMMAGARD 69 adalimumab Humira 69 galiximab 69 oral rivaroxaban 69 ® natalizumab 69 Tyrima 69 Immunotherapeutic 69 microtubule inhibitor 69 IAP inhibitor 69 BAY #-# 69 clevidipine 69 RNAi therapeutic targeting 69 posaconazole 69 Sudhir Agrawal D.Phil 69 VAPRISOL 69 otelixizumab 69 Lubiprostone 69 pharmacokinetic PK study 69 Tavocept 69 Dacogen decitabine 69 BRAF inhibitor 69 ADAGIO study 69 RH1 69 somatostatin analogue 69 SERMs 69 radezolid 69 CA4P 69 ONCONASE R 69 MYLOTARG 69 eculizumab therapy 69 small molecule thrombopoietin 69 DACH platinum 69 TNF Tumor Necrosis Factor 69 zanolimumab 69 Panzem 69 axitinib 69 xanthine oxidase inhibitor 69 Rebif ® 69 MEK inhibitor 69 radiation sensitizer 69 EGFR HER2 69 recurrent glioblastoma multiforme 69 HGS# 69 ACTEMRA TM 69 varespladib 69 Ceflatonin 69 PDE# inhibitors 69 ON #.Na 69 Proquin XR 69 Zorbtive TM 69 Interferon beta 69 Granulocyte Colony Stimulating Factor 69 Troxatyl 69 Daclizumab 69 ospemifene 69 CA9 SCAN 69 Trofex 69 GRNVAC1 69 UPLYSO 69 cetuximab Erbitux 69 epigenetic therapies 69 mTOR inhibitors 69 incyclinide 69 cannabinor 69 pharmacodynamic properties 69 Interferon beta 1a 69 Aliskiren 69 tumor xenograft models 69 hypoxia activated prodrug 69 Phase Ib II 69 herpetic keratitis 69 SinuNase ™ 69 Fibrillex TM 68 ulimorelin 68 Interferon alpha 68 AEG# 68 Squalamine 68 immune modulatory 68 TG# [003] 68 IRX 2 68 PROCHYMAL 68 KL4 surfactant 68 Anavex #-# 68 Dasatinib 68 huC# DM4 68 CoFactor 68 multikinase inhibitor 68 Phase Ib clinical 68 aerosolized KL4 surfactant 68 BRIM2 68 Trandolapril 68 CLORETAZINE TM VNP#M 68 tocilizumab 68 QLT# 68 metaglidasen 68 solithromycin 68 Nexavar ® 68 LEUKINE 68 Hsp# Inhibitor 68 OncoVEX 68 R roscovitine 68 PKC# 68 Alferon N 68 tramiprosate Alzhemed TM 68 PEGylated interferon beta 1a 68 uric acid lowering 68 paclitaxel Taxol ® 68 anticancer compound 68 Fc fusion protein 68 Shigamabs ® 68 histone deacetylase inhibitor 68 ADP receptor antagonist 68 YONDELIS R 68 Aplidin R 68 immunotherapeutic vaccine 68 Telintra 68 orally dosed 68 Spiegelmer ® 68 KRN# 68 imatinib Gleevec ® 68 antitumor efficacy 68 Amplimexon 68 novel histone deacetylase 68 RoACTEMRA 68 Orazol 68 refractory gout 68 neovascular diseases 68 samalizumab 68 ibandronate 68 CD3 monoclonal antibody 68 CRLX# 68 immunomodulation 68 S/GSK# 68 delafloxacin 68 bexarotene 68 PEGylated interferon 68 TBC# 68 oral FTY# 68 R#/MEM 68 ACZ# 68 Decitabine 68 Aviptadil 68 ProSavin 68 crizotinib PF # 68 NP2 Enkephalin 68 OvaRex ® MAb 68 rBChE 68 Irinotecan 68 bortezomib Velcade 68 ganaxolone 68 immunomodulatory properties 68 Gleevec resistant 68 seliciclib CYC# 68 humanized anti 68 Vandetanib 68 Golimumab 68 investigational monoclonal antibody 68 ATL# [001] 68 Allovectin 7 68 R#/MEM # 68 Sym# 68 alemtuzumab Campath 68 Targretin capsules 68 anticancer agent 68 GFT# 68 Lixivaptan 68 Phase 1b trial 68 Denufosol 68 USL# 68 hyperphenylalaninemia HPA due 68 Dacogen injection 68 goserelin 68 Octreolin 68 isoform selective 68 rilonacept 68 tubulin inhibitor 68 Simulect 68 Firazyr 68 novel oral anticoagulant 68 phase IIb trial 68 GLYX 68 sargramostim 68 ALN TTR 68 acadesine 68 factor Xa inhibitor 68 HCD# [002] 68 Fludara ® 68 LymphoStat B TM 68 Ocrelizumab 68 paclitaxel Taxol R 68 hyaluronidase enzyme 68 sitaxsentan 68 cediranib 68 AMPK activators 68 Pyridorin 68 HuMax CD4 68 SYN# 68 SinuNase 68 cathepsin K inhibitor 68 SinuNase TM 68 ORENCIA ® 68 Tezampanel 68 indibulin 68 CR# vcMMAE 68 RhuDex R 68 Phase IIb clinical trials 68 ESBA# 68 pharmacodynamic effects 68 SUTENT ® 68 CYT# 68 HIF PHI 68 Proxinium TM 68 Laquinimod 68 miglustat 68 pharmacological chaperone 68 recurrent herpes labialis 68 Talabostat 68 Blinatumomab 68 orally inhaled 68 secondary hyperparathyroidism 68 sorafenib Nexavar 68 IAP inhibitors 68 Vernakalant 68 pomalidomide 68 pediatric acute lymphoblastic 68 Mipomersen 68 Microplasmin 68 LB# [003] 68 Pertuzumab 68 placebo controlled clinical 68 opioid induced bowel dysfunction 68 DEB# 68 cystinosis patients 68 Omacetaxine 68 desvenlafaxine succinate 68 Teriflunomide 68 Seliciclib 68 somatostatin analog 68 ruxolitinib 68 Aloxi injection 68 gemcitabine Gemzar ® 68 GV# [001] 68 ara C 68 aurora kinase 68 Solulin 68 XYOTAX TM 68 RLY# 68 maximally tolerated dose 68 PREOS R 68 CYT# QbG# 68 methylnaltrexone 68 ORENCIA R 68 2 methoxyestradiol 68 systemically administered 68 tiapamil 68 talactoferrin 68 PEG IFN 68 Cethrin 68 resminostat 68 oral beclomethasone dipropionate 68 C1 INH 68 TransVax ™ 68 nalbuphine ER 68 calcineurin inhibitor 68 pain palliation 68 TELINTRA 68 Cethromycin 68 multiple myeloma MM 68 effector function 68 PEGylated 68 potent antiproliferative 68 MyVax R 68 Chemophase 68 humanised monoclonal antibody 68 anti angiogenic agent 67 castrate resistant prostate cancer 67 ZD# [001] 67 antiarrhythmic drug 67 ancrod 67 Protelos 67 verteporfin 67 Angiolix 67 GRN# 67 tezampanel 67 Thiarabine 67 rHuPH# 67 Tesetaxel 67 Phase 2a trial 67 HCV protease inhibitors 67 orally inhaled migraine 67 Tyrosine Kinase Inhibitor 67 Dalbavancin 67 rufinamide 67 Pimavanserin 67 immunomodulatory 67 sodium glucose cotransporter 67 pouchitis 67 RezularTM 67 inhaled treprostinil 67 PrevOnco ™ 67 Omalizumab 67 uricase 67 Lenalidomide 67 tumor necrosis 67 histamine dihydrochloride 67 oral methylnaltrexone 67 r hGH 67 Akt inhibitor 67 efficacy tolerability 67 ONCASPAR 67 Icatibant 67 kidney urologic 67 TO AVOID PREGNANCY WHILE 67 Anticalin ® 67 MAb 67 refractory chronic lymphocytic 67 IFN beta 67 TRX1 67 Triapine R 67 bevacizumab Avastin ® 67 omacetaxine mepesuccinate 67 MoxDuo IR 67 Annamycin 67 AVONEX ® 67 Phase IIB 67 SIR Spheres 67 HMG CoA reductase inhibitors 67 peripherally acting 67 TPI ASM8 67 deferiprone 67 targeted antifolate 67 non nucleoside inhibitor 67 vivo potency 67 Phase #/#a trial 67 Virulizin R 67 depsipeptide 67 acyclovir Lauriad ® 67 HSP# inhibitor 67 Epratuzumab 67 trabedersen 67 Zybrestat 67 OMNARIS Nasal Spray 67 antiangiogenic therapy 67 entinostat 67 RhuDex 67 Rasagiline 67 torezolid phosphate 67 RhuDex TM 67 Triolex 67 ALVESCO R 67 RNAi therapeutic targeting PCSK9 67 EOquin 67 fluticasone furoate 67 cariprazine 67 mapatumumab 67 assessing T DM1 67 mTOR inhibition 67 selective agonist 67 Nanobody 67 mecamylamine 67 Calcitonin 67 alefacept 67 VELCADE melphalan 67 analgesic efficacy 67 cardioprotective effects 67 pharmacokinetics PK 67 INTEGRILIN ® 67 INT# [002] 67 JAK3 inhibitor 67 Pivotal Phase III 67 Ophena 67 oxaliplatin Eloxatin 67 Vaprisol 67 oral antiviral 67 Darusentan 67 budesonide foam 67 Fx #A 67 evaluating Actimmune 67 Mycophenolate Mofetil 67 antiangiogenic 67 PROSTVAC VF 67 demonstrated antitumor activity 67 Candesartan 67 OncoGel 67 anti leukemic 67 neuroprotective properties 67 MEK inhibitors 67 sipuleucel T 67 NXL# 67 interferon beta therapy 67 metastatic castration resistant 67 Revlimid lenalidomide 67 Crohn disease CD 67 Insulin PH# 67 inhaled iloprost 67 multitargeted 67 Losartan 67 xenograft models 67 Hedgehog Pathway Inhibitor 67 bronchodilatory 67 Noxafil 67 talabostat 67 hereditary deficiency 67 MAXY G# 67 ISTODAX 67 VEGF inhibitors 67 visilizumab 67 including eniluracil ADH 67 pitavastatin 67 Targretin 67 diabetic gastroparesis 67 Benlysta belimumab 67 CIMZIA R 67 obatoclax 67 Alzhemed TM 67 Voreloxin 67 Romidepsin 67 Increlex ® 67 Actimmune ® 67 Rigel R# 67 TYZEKA 67 Tamibarotene 67 somatostatin analogues 67 highly selective inhibitor 67 favorable pharmacokinetic profile 67 glucokinase activator 67 Alocrest 67 boosted protease inhibitor 67 tipranavir 67 pharmacodynamic profile 67 Zalypsis 67 Vilazodone 67 trastuzumab DM1 T DM1 67 Raptiva ® 67 MAP# 67 ATL/TV# 67 TRIOLEX 67 Perforomist ™ Inhalation Solution 67 Adalimumab 67 inhaled liposomal ciprofloxacin 67 DXL# 67 PHX# 67 oxybutynin gel 67 REMINYL ® 67 caspofungin 67 interleukin IL -# 67 MEND CABG II 67 Preclinical studies suggest 67 LAB CGRP 67 bendamustine 67 Exelixis XL# 67 GRNCM1 67 ARIKACE 67 rhIGF-I/rhIGFBP-3 67 Saforis 67 Ranolazine 67 biliary tract cancer 67 Azacitidine 67 LHRH antagonist 67 chimeric monoclonal antibody 67 HIV coinfected 67 rALLy clinical trial 67 ATL# [002] 67 anti EGFR antibody 67 murine model 67 alagebrium 67 DermaVir Patch 67 BAL# [002] 67 phase IIa 67 RSD# oral 67 protease inhibitor PI 67 Diamyd R 67 plasma kallikrein inhibitor 67 NGX# 67 EGS# 67 GnRH antagonist 67 mRCC 67 custirsen 67 administered intranasally 67 Onrigin 67 AGILECT R 67 mu opioid receptor antagonist 67 ChronVac C R 67 AQ4N 67 phase IIb study 67 pharmacokinetic PK profile 67 oral talactoferrin 67 Ophena TM 67 Guanilib 67 HDL Selective Delipidation 67 baminercept 67 docetaxel Taxotere R 67 FDA APPROVES 67 TLR8 agonist 67 vaso occlusive crisis 67 multi kinase inhibitor 67 brand ciclesonide HFA 67 Enzastaurin 67 Kamada AAT 67 LEVADEX ™ 67 Panzem ® 67 Prestara 67 Cellegesic 67 IMiDs ® 67 gemcitabine Gemzar 67 Phase #b/#a trial 67 choroidal neovascularization 67 Valdoxan 67 Ixempra 67 Doxil ® 67 selective S#P# receptor agonist 67 hypereosinophilic syndrome 67 ritonavir boosted 67 treat benign prostatic 67 schizophrenia CIAS 67 Neulasta ® 67 EZN 67 IRESSA 67 HyACT 67 selective antagonist 67 neratinib 67 Zirgan 67 SAR# [004] 67 liposomal amphotericin B 67 tolerability profiles 67 Fidaxomicin 67 essential thrombocythemia ET 67 peptide conjugated 67 anti CD3 67 #I TM# 67 chronic eosinophilic leukemia 67 CD# CEA 67 CD# antibody [001] 67 oral ghrelin agonist 67 anti angiogenic agents 67 ularitide 67 antiangiogenic agents 67 Anti VEGF 67 TOLAMBA 67 5 HT2C receptor 67 pimecrolimus 67 eosinophilic asthma 67 oxymorphone ER 67 INSPIRE Trial Phase III 67 clinical pharmacology studies 67 CaPre TM 67 Zemplar Capsules 67 Fondaparinux 67 pioglitazone HCl 67 IMC #B 67 HIF PH inhibitors 67 AMEVIVE 67 Lenocta 67 Phase IIb III 67 MoxDuo 67 trospium 67 therapeutic monoclonal antibody 67 Phase Ib IIa 67 Onalta 67 WILEX 67 Cimzia ® certolizumab pegol 67 Pharmacokinetics PK 67 dexpramipexole 67 oral JAK1 67 glucagon receptor 66 daptomycin 66 CTA# 66 GOUT 66 postoperative ileus 66 relapsed multiple myeloma 66 Kepivance 66 Ataluren 66 ocrelizumab 66 senicapoc 66 Cloretazine R 66 lintuzumab 66 Vitaxin 66 HDAC Inhibitor 66 ALN TTR# 66 hA# 66 adenoviral 66 gastrointestinal stromal tumors GISTs 66 IV Busulfex 66 denileukin diftitox 66 isotype 66 LT NS# 66 ACV1 66 inhaled AAT 66 anticancer activity 66 FOLFOX6 chemotherapy regimen 66 sunitinib Sutent ® 66 CRD5 66 tyrosine kinase inhibitor 66 ZYBRESTAT 66 levocetirizine 66 topical ophthalmic 66 nitazoxanide 66 lapatinib Tykerb 66 virus HCV protease inhibitor 66 IMC A# 66 personalized immunotherapy 66 Interferon beta 1b 66 Trastuzumab 66 ALK inhibitor 66 desvenlafaxine 66 CIPN 66 tigecycline 66 malignant ascites 66 olmesartan 66 recurrent glioblastoma 66 Interferon Beta 66 metastatic bone 66 Dyloject TM 66 THALOMID 66 adecatumumab MT# 66 intravenous immunoglobulin IVIg 66 Temsirolimus 66 zileuton 66 noninfectious uveitis 66 relapsed ALL 66 leukotriene receptor antagonists 66 Civacir 66 neurotrophic 66 bortezomib Velcade R 66 glatiramer 66 esophageal candidiasis 66 antiangiogenesis 66 G#DT 66 inhibitor RG# 66 protein kinase inhibitor 66 orally bioavailable 66 adefovir dipivoxil 66 novel peptide 66 fibrotic disease 66 HuMax TAC 66 LHRH receptor positive 66 PAOD 66 Phenoptin 66 INS# [001] 66 IL# PE#QQR 66 pharmacokinetic interactions 66 MNTX 66 panitumumab Vectibix 66 Meets Primary Endpoint 66 CAELYX 66 Genentech Rituxan 66 GVAX ® 66 tesmilifene 66 Fulvestrant 66 antifibrotic 66 dacetuzumab 66 PhG alpha 1 66 anti amnesic 66 Xelox 66 prostanoid 66 Glypromate 66 metastatic neuroendocrine tumors 66 Ciclesonide 66 JAK2 inhibitors 66 vinca alkaloid 66 gastrointestinal stromal tumors GIST 66 Hedgehog antagonist 66 lipid lowering therapies 66 CYC# 66 Pirfenidone 66 DIFICID 66 INCB# [002] 66 glatiramer acetate 66 PROMACTA 66 EXPAREL ™ 66 Thiovir 66 PEGylated anti 66 AOD# [002] 66 antiangiogenic agent 66 agomelatine 66 HuMax 66 mouse xenograft models 66 BCX# 66 NOX E# 66 pathophysiological effects 66 ongoing Phase 1b 66 FOLFOX6 66 HGS ETR1 66 leukotriene receptor antagonist 66 imexon 66 systemic RNAi therapeutic 66 apremilast 66 gonadotrophin releasing hormone GnRH 66 antiviral efficacy 66 Tarvacin 66 Afatinib 66 inhaled formulation 66 severe gastroparesis 66 MEK inhibitor RDEA# 66 vinorelbine tartrate 66 SomatoKine 66 BZL# 66 PRTX 66 CCX# B 66 cetuximab Erbitux ® 66 cetuximab Erbitux R 66 Amrubicin 66 abacavir Ziagen 66 Diabetic Neuropathy 66 heavily pretreated 66 plasma pharmacokinetics 66 Campath ® 66 faropenem medoxomil 66 oxypurinol 66 Cloretazine ® 66 NS#/#A protease 66 Octreotide 66 Tocilizumab 66 EP #R 66 Zoraxel 66 aripiprazole Abilify 66 Privigen 66 trastuzumab DM1 66 OvaRex MAb 66 paclitaxel Taxol 66 Actemra tocilizumab 66 ASTEROID 66 NEUGENE 66 Genasense ® 66 investigational therapies 66 GLP1 agonist 66 AVAPRO 66 Resten NG 66 ALN PCS 66 biologic DMARD 66 Copegus ribavirin 66 bosentan 66 pyridostigmine 66 Urocidin 66 tolevamer 66 morphometric vertebral fractures 66 Cloretazine R VNP#M 66 KRAS mutations occur 66 PDE4 inhibitors 66 Synavive 66 6R BH4 66 RGB # 66 eltrombopag 66 Phase IIa trial 66 hoFH 66 Ziprasidone 66 administered subcutaneously 66 5 HT3 antagonist 66 MyVax ® 66 Initiate Phase 66 Serdolect ® 66 trabectedin 66 synthetic retinoid 66 methylnaltrexone bromide 66 Multimeric 66 Pagoclone 66 Arimidex anastrozole 66 NAVISTAR R 66 Certolizumab pegol 66 superficial bladder cancer 66 rNAPc2 66 APOPTONE 66 Ranibizumab 66 bicifadine 66 tafamidis 66 vapreotide acetate 66 etanercept Enbrel 66 Teysuno 66 Prodarsan ® 66 Parathyroid Hormone 66 myeloproliferative disorders 66 APTIVUS r 66 molecular biomarkers 66 FUSILEV enhances